Cargando…

Exosomes From Human Cardiac Progenitor Cells for Therapeutic Applications: Development of a GMP-Grade Manufacturing Method

Exosomes, nanosized membrane vesicles secreted by cardiac progenitor cells (Exo-CPC), inhibit cardiomyocyte apoptosis under stress conditions, promote angiogenesis in vitro, and prevent the early decline in cardiac function after myocardial infarction in vivo in preclinical rat models. The recogniti...

Descripción completa

Detalles Bibliográficos
Autores principales:	Andriolo, Gabriella, Provasi, Elena, Lo Cicero, Viviana, Brambilla, Andrea, Soncin, Sabrina, Torre, Tiziano, Milano, Giuseppina, Biemmi, Vanessa, Vassalli, Giuseppe, Turchetto, Lucia, Barile, Lucio, Radrizzani, Marina
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2018
Materias:	Physiology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6117231/ https://www.ncbi.nlm.nih.gov/pubmed/30197601 http://dx.doi.org/10.3389/fphys.2018.01169

Ejemplares similares

Bone marrow-derived cells for cardiovascular cell therapy: an optimized GMP method based on low-density gradient improves cell purity and function
por: Radrizzani, Marina, et al.
Publicado: (2014)

Exosomal Expression of CXCR4 Targets Cardioprotective Vesicles to Myocardial Infarction and Improves Outcome after Systemic Administration
por: Ciullo, Alessandra, et al.
Publicado: (2019)

Ultrastructural Evidence of Exosome Secretion by Progenitor Cells in Adult Mouse Myocardium and Adult Human Cardiospheres
por: Barile, Lucio, et al.
Publicado: (2012)

Exosomes for Intramyocardial Intercellular Communication
por: Cervio, Elisabetta, et al.
Publicado: (2015)

Inflammatory extracellular vesicles prompt heart dysfunction via TRL4-dependent NF-κB activation
por: Biemmi, Vanessa, et al.
Publicado: (2020)

Inflammatory extracellular vesicles prompt heart dysfunction via TLR4-dependent NF-κB activation: Erratum
por: Biemmi, Vanessa, et al.
Publicado: (2023)

Efficacy of Intraoperative Vein Graft Storage Solutions in Preserving Endothelial Cell Integrity during Coronary Artery Bypass Surgery
por: Toto, Francesca, et al.
Publicado: (2022)

Structural and Electrophysiological Changes in a Model of Cardiotoxicity Induced by Anthracycline Combined With Trastuzumab
por: Altomare, Claudia, et al.
Publicado: (2021)

Human Cardiospheres as a Source of Multipotent Stem and Progenitor Cells
por: Barile, Lucio, et al.
Publicado: (2013)

ALDH1A3 Is the Key Isoform That Contributes to Aldehyde Dehydrogenase Activity and Affects in Vitro Proliferation in Cardiac Atrial Appendage Progenitor Cells
por: Puttini, Stefania, et al.
Publicado: (2018)

Cardiomyocyte-targeting exosomes from sulforaphane-treated fibroblasts affords cardioprotection in infarcted rats
por: Papini, Gaia, et al.
Publicado: (2023)

A practical approach for the validation of sterility, endotoxin and potency testing of bone marrow mononucleated cells used in cardiac regeneration in compliance with good manufacturing practice
por: Soncin, Sabrina, et al.
Publicado: (2009)

Characterization of Cardiac-Resident Progenitor Cells Expressing High Aldehyde Dehydrogenase Activity
por: Roehrich, Marc-Estienne, et al.
Publicado: (2013)

Role of Mitogen-Activated Protein Kinases in Myocardial Ischemia-Reperfusion Injury during Heart Transplantation
por: Vassalli, Giuseppe, et al.
Publicado: (2012)

An exosomal-carried short periostin isoform induces cardiomyocyte proliferation
por: Balbi, Carolina, et al.
Publicado: (2021)

Sphingolipid composition of circulating extracellular vesicles after myocardial ischemia
por: Burrello, J., et al.
Publicado: (2020)

P1405: IN-DEPTH GENOME INTEGRITY EVALUATION AND GMP-COMPLIANT MANUFACTURING OF HDR GENE EDITED CD4+ T CELLS FOR THE TREATMENT OF HYPER IGM 1
por: Canarutto, Daniele, et al.
Publicado: (2023)

Ticagrelor Enhances Release of Anti-Hypoxic Cardiac Progenitor Cell-Derived Exosomes Through Increasing Cell Proliferation In Vitro
por: Casieri, Valentina, et al.
Publicado: (2020)

An extracellular vesicle epitope profile is associated with acute myocardial infarction
por: Burrello, Jacopo, et al.
Publicado: (2020)

GMP/ISO quality audit manual for healthcare manufacturers and their suppliers /
por: Steinborn, Leonard
Publicado: (2003)

Circulating extracellular vesicles are endowed with enhanced procoagulant activity in SARS-CoV-2 infection
por: Balbi, Carolina, et al.
Publicado: (2021)

Sildenafil attenuates hypoxic pulmonary remodelling by inhibiting bone marrow progenitor cells
por: Favre, Shirley, et al.
Publicado: (2016)

Nitric Oxide–cGMP Pathway Modulation in an Experimental Model of Hypoxic Pulmonary Hypertension
por: Reinero, Melanie, et al.
Publicado: (2021)

Cell-based medicinal products and the development of GMP-compliant processes and manufacturing
por: Romagnoli, Luca, et al.
Publicado: (2011)

Good Manufacturing Practice (GMP) Compliance for Phage Therapy Medicinal Products
por: Bretaudeau, Laurent, et al.
Publicado: (2020)

GMP-Grade Manufacturing of T Cells Engineered to Express a Defined γδTCR
por: Straetemans, Trudy, et al.
Publicado: (2018)

Moving analytical ultracentrifugation software to a good manufacturing practices (GMP) environment
por: Savelyev, Alexey, et al.
Publicado: (2020)

Polyclonal Regulatory T Cell Manufacturing Under cGMP: A Decade of Experience
por: Balcerek, Joanna, et al.
Publicado: (2021)

Cost benefit of investment on quality in pharmaceutical manufacturing: WHO GMP pre- and post-certification of a Nigerian pharmaceutical manufacturer
por: Anyakora, Chimezie, et al.
Publicado: (2017)

Risk stratification of patients with SARS-CoV-2 by tissue factor expression in circulating extracellular vesicles
por: Burrello, Jacopo, et al.
Publicado: (2022)

Direct Phosphorylation of Psilocin Enables Optimized cGMP Kilogram-Scale Manufacture of Psilocybin
por: Kargbo, Robert B., et al.
Publicado: (2020)

Cell-Based Therapy Manufacturing in Stirred Suspension Bioreactor: Thoughts for cGMP Compliance
por: Nath, Suman C., et al.
Publicado: (2020)

Acceleration of Translational Mesenchymal Stromal Cell Therapy Through Consistent Quality GMP Manufacturing
por: Jayaraman, Premkumar, et al.
Publicado: (2021)

GMP-conformant on-site manufacturing of a CD133(+) stem cell product for cardiovascular regeneration
por: Skorska, Anna, et al.
Publicado: (2017)

Nanopharmaceutics: Part I—Clinical Trials Legislation and Good Manufacturing Practices (GMP) of Nanotherapeutics in the EU
por: Souto, Eliana B., et al.
Publicado: (2020)

Manufacturing Therapeutic Exosomes: from Bench to Industry
por: Ahn, So-Hee, et al.
Publicado: (2022)

Characterization of Myelomonocytoid Progenitor Cells with Mesenchymal Differentiation Potential Obtained by Outgrowth from Pancreas Explants
por: Roehrich, Marc-Estienne, et al.
Publicado: (2012)

Notch pathway activation enhances cardiosphere in vitro expansion
por: Secco, Ilaria, et al.
Publicado: (2018)

cGMP-Manufactured Human Induced Pluripotent Stem Cells Are Available for Pre-clinical and Clinical Applications
por: Baghbaderani, Behnam Ahmadian, et al.
Publicado: (2015)

GMP-Compliant Manufacturing of NKG2D CAR Memory T Cells Using CliniMACS Prodigy
por: Fernández, Lucía, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_rl91cdtjpav468ni4j88q8u6ml